{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:59Z","timestamp":1793035919558,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer-related death worldwide, and the molecular pathogenesis and development of HCC are largely unknown. In the present study, we found that KIF4A expression was upregulated in HCC (678 samples, <jats:italic>P<\/jats:italic>\u2009=\u20092.03E-8) based on a meta-analysis of Oncomine database. We further confirmed that both KIF4A mRNA and protein expressions were overexpressed in human HCC tumour tissues as well as cancer cell lines. Higher KIF4A expression was correlated with poorer overall survival (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and disease-free survival (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0337) in HCC patients. We constructed in vitro KIF4A overexpression and depletion HCC cell models. KIF4A overexpression significantly enhanced cellular proliferation and clonogenic abilities, whereas KIF4A depletion caused a dramatic increase of cells with abnormal chromosome segregation and subsequently resulted in augmentation of apoptosis in HCC cells. In addition, we demonstrated that KIF4A depletion was related to inhibition of Akt kinase activity and induction of intrinsic apoptosis signaling pathway. Taken together, KIF4A may act as a prognostic biomarker and potential therapeutic target in human HCC.<\/jats:p>","DOI":"10.1038\/s41419-017-0114-4","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T09:03:11Z","timestamp":1517562191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Yanlin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"114_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer"},{"key":"114_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","volume":"11","author":"A Forner","year":"2014","unstructured":"Forner, A., Gilabert, M., Bruix, J. & Raoul, J. L. Treatment of intermediate-stage hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 11, 525\u2013535 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"114_CR3","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2, 16018 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"114_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12\u201327 (2012).","journal-title":"Cell"},{"key":"114_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jhep.2013.01.014","volume":"58","author":"Y Huang","year":"2013","unstructured":"Huang, Y., Tai, A. W., Tong, S. & Lok, A. S. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J. Hepatol. 58, 1068\u20131073 (2013).","journal-title":"J. Hepatol."},{"key":"114_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1053\/j.gastro.2011.06.048","volume":"141","author":"Y Huang","year":"2011","unstructured":"Huang, Y., Tong, S., Tai, A. W., Hussain, M. & Lok, A. S. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Gastroenterology 141, 1412\u20131421 (2011).","journal-title":"Gastroenterology"},{"key":"114_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrc1714","volume":"5","author":"GJ Kops","year":"2005","unstructured":"Kops, G. J., Weaver, B. A. & Cleveland, D. W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer. 5, 773\u2013785 (2005).","journal-title":"Nat. Rev. Cancer."},{"key":"114_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/cas.12138","volume":"104","author":"X Liu","year":"2013","unstructured":"Liu, X., Gong, H. & Huang, K. Oncogenic role of kinesin proteins and targeting kinesin therapy. Cancer Sci. 104, 651\u2013656 (2013).","journal-title":"Cancer Sci."},{"key":"114_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1083\/jcb.200408113","volume":"167","author":"CJ Lawrence","year":"2004","unstructured":"Lawrence, C. J. et al. A standardized kinesin nomenclature. J. Cell. Biol. 167, 19\u201322 (2004).","journal-title":"J. Cell. Biol."},{"key":"114_CR10","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1073\/pnas.111145398","volume":"98","author":"H Miki","year":"2001","unstructured":"Miki, H., Setou, M., Kaneshiro, K. & Hirokawa, N. All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl Acad. Sci.USA 98, 7004\u20137011 (2001).","journal-title":"Proc. Natl Acad. Sci.USA"},{"key":"114_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbrc.2008.05.065","volume":"372","author":"G Wu","year":"2008","unstructured":"Wu, G. & Chen, P. L. Structural requirements of chromokinesin Kif4A for its proper function in mitosis. Biochem. Biophys. Res. Commun. 372, 454\u2013458 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"114_CR12","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1158\/1078-0432.CCR-07-1328","volume":"13","author":"M Taniwaki","year":"2007","unstructured":"Taniwaki, M. et al. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin. Cancer Res.\n                           13, 6624\u20136631 (2007).","journal-title":"Clin. Cancer Res."},{"key":"114_CR13","doi-asserted-by":"publisher","first-page":"e85951","DOI":"10.1371\/journal.pone.0085951","volume":"8","author":"Y Minakawa","year":"2013","unstructured":"Minakawa, Y. et al. Kinesin family member 4A: a potential predictor for progression of human oral cancer. PLoS ONE 8, e85951 (2013).","journal-title":"PLoS ONE"},{"key":"114_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/gcc.20418","volume":"46","author":"G Narayan","year":"2007","unstructured":"Narayan, G. et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46, 373\u2013384 (2007).","journal-title":"Genes Chromosomes Cancer"},{"key":"114_CR15","doi-asserted-by":"publisher","first-page":"e63204","DOI":"10.1371\/journal.pone.0063204","volume":"8","author":"D Colak","year":"2013","unstructured":"Colak, D. et al. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS ONE 8, e63204 (2013).","journal-title":"PLoS ONE"},{"key":"114_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/1541-7786.MCR-13-0459","volume":"12","author":"JX Zou","year":"2014","unstructured":"Zou, J. X. et al. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance. Mol. Cancer Res. 12, 539\u2013549 (2014).","journal-title":"Mol. Cancer Res."},{"key":"114_CR17","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.1073\/pnas.0401994101","volume":"101","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci.USA 101, 9309\u20139314 (2004).","journal-title":"Proc. Natl Acad. Sci.USA"},{"key":"114_CR18","first-page":"508","volume":"2","author":"D Schnerch","year":"2012","unstructured":"Schnerch, D. et al. Cell cycle control in acute myeloid leukemia. Am. J. Cancer Res. 2, 508\u2013528 (2012).","journal-title":"Am. J. Cancer Res."},{"key":"114_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3892\/ijmm.2017.2936","volume":"39","author":"Y Xu","year":"2017","unstructured":"Xu, Y. et al. Kif4 regulates the expression of VEGFR1 through the PI3K\/Akt signaling pathway in RAW264.7 monocytes\/macrophages. Int. J. Mol. Med. 39, 1285\u20131290 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"114_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2741\/4320","volume":"20","author":"Z Hao","year":"2015","unstructured":"Hao, Z. & Huang, S. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy. Front. Biosci. 20, 474\u2013490 (2015).","journal-title":"Front. Biosci."},{"key":"114_CR21","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1053\/j.gastro.2009.08.005","volume":"137","author":"DF Calvisi","year":"2009","unstructured":"Calvisi, D. F. et al. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology 137, 1816\u20131826 (2009). e1811-1810.","journal-title":"Gastroenterology"},{"key":"114_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.23","volume":"46","author":"H Xu","year":"2014","unstructured":"Xu, H. et al. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking thep27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Exp. Mol. Med. 46, e97 (2014).","journal-title":"Exp. Mol. Med."},{"key":"114_CR23","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1002\/cncr.25461","volume":"116","author":"Y Yu","year":"2010","unstructured":"Yu, Y. & Feng, Y. M. The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 116, 5150\u20135160 (2010).","journal-title":"Cancer"},{"key":"114_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.200401142","volume":"166","author":"M Mazumdar","year":"2004","unstructured":"Mazumdar, M., Sundareshan, S. & Misteli, T. Human chromokinesin KIF4A functions in chromosome condensation and segregation. J. Cell. Biol. 166, 613\u2013620 (2004).","journal-title":"J. Cell. Biol."},{"key":"114_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrc2663","volume":"9","author":"TG Cotter","year":"2009","unstructured":"Cotter, T. G. Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer 9, 501\u2013507 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"114_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.addr.2009.07.017","volume":"61","author":"BL Stiles","year":"2009","unstructured":"Stiles, B. L. PI-3-K and AKT: onto the mitochondria. Adv. Drug. Deliv. Rev. 61, 1276\u20131282 (2009).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"114_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ajg.2010.404","volume":"106","author":"Y Huang","year":"2011","unstructured":"Huang, Y. & Lok, A. S. Viral factors and outcomes of chronic HBV infection. Am. J. Gastroenterol. 106, 93\u201395 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"114_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep35917","volume":"6","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression. Sci. Rep. 6, 35917 (2016).","journal-title":"Sci. Rep."},{"key":"114_CR29","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jnci\/djn243","volume":"100","author":"HI Yang","year":"2008","unstructured":"Yang, H. I. et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J. Natl. Cancer. Inst. 100, 1134\u20131143 (2008).","journal-title":"J. Natl. Cancer. Inst."},{"key":"114_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1056\/NEJM200211213472119","volume":"347","author":"A Geier","year":"2002","unstructured":"Geier, A., Gartung, C., Dietrich, C. G. & Hepatitis, B. e Antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 347,1721\u20131722 (2002)","journal-title":"N. Engl. J. Med."},{"key":"114_CR31","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3892\/mmr.2015.3792","volume":"12","author":"CL Zhu","year":"2015","unstructured":"Zhu, C. L. et al. Hepatitis B virus upregulates the expression of kinesin family member 4A. Mol. Med. Rep. 12, 3503\u20133507 (2015).","journal-title":"Mol. Med. Rep."},{"key":"114_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/cr.2011.181","volume":"22","author":"X Liu","year":"2012","unstructured":"Liu, X. et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell. Res. 22, 321\u2013332 (2012).","journal-title":"Cell. Res."},{"key":"114_CR33","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1038\/sj.onc.1208459","volume":"24","author":"F Jiang","year":"2005","unstructured":"Jiang, F., Caraway, N. P., Li, R. & Katz, R. L. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 24, 3409\u20133418 (2005).","journal-title":"Oncogene"},{"key":"114_CR34","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315\u20132319 (2006).","journal-title":"Nat. Protoc."},{"key":"114_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bcp.2009.08.022","volume":"79","author":"PC Chiang","year":"2010","unstructured":"Chiang, P. C. et al. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. Biochem. Pharmacol. 79, 162\u2013171 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"114_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1\u20136 (2004).","journal-title":"Neoplasia"},{"key":"114_CR37","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.21622","volume":"45","author":"E Wurmbach","year":"2007","unstructured":"Wurmbach, E. et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. J. Hepatol. 45, 938\u2013947 (2007).","journal-title":"J. Hepatol."},{"key":"114_CR38","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler, S. et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70, 10202\u201310212 (2010).","journal-title":"Cancer Res."},{"key":"114_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2119\/molmed.2008.00110","volume":"15","author":"VR Mas","year":"2009","unstructured":"Mas, V. R. et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol. Med. 15, 85\u201394 (2009).","journal-title":"Mol. Med."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0114-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0114-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:39:47Z","timestamp":1671536387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0114-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0114-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"13 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"141"}}